Senzer’s unique inhalation technology is founded on over 330 granted and 220 pending patents bridging all aspects of both the device and formulation. The patents span the globe, ensuring comprehensive coverage and protection for years to come. The company has an ongoing focus on the development of new intellectual property, with extensive in-house and outsourced capabilities.
Over 550 patents filed with more than 330 granted to date under Senzer's control, including 13 specific to cannabinoid formulations, until at least 2037
Design Rights and Trademarks for leading products across EU, US and Canada with further pending